Vascular Biogenics Quote - VBLT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.156

Bid

0.1598

Ask

0.1599

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

1.404M

Previous Close

0.156

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

9,001,000

Dividend Yield

PE Ratio

-0.20

Earnings Per Share (EPS)

-1.25

Revenue

310k

Net Profit

-11.26M

Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumo... Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.vblrx.com

Headquarters

Modi'in-maccabim-re'ut, Center, Isr

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

VBLT - Frequently Asked Questions (FAQ)

What is the current Vascular Biogenics share price?

The current share price of Vascular Biogenics is US$ 0.156

How many Vascular Biogenics shares are in issue?

Vascular Biogenics has 9,001,000 shares in issue

What is the market cap of Vascular Biogenics?

The market capitalisation of Vascular Biogenics is USD 1.4M

What is the 1 year trading range for Vascular Biogenics share price?

Vascular Biogenics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Vascular Biogenics?

The price to earnings ratio of Vascular Biogenics is -0.2

What is the cash to sales ratio of Vascular Biogenics?

The cash to sales ratio of Vascular Biogenics is 7.27

What is the reporting currency for Vascular Biogenics?

Vascular Biogenics reports financial results in USD

What is the latest annual turnover for Vascular Biogenics?

The latest annual turnover of Vascular Biogenics is USD 310k

What is the latest annual profit for Vascular Biogenics?

The latest annual profit of Vascular Biogenics is USD -11.26M

What is the registered address of Vascular Biogenics?

The registered address for Vascular Biogenics is 8 HASATAT ST, MODI'IN-MACCABIM-RE'UT, CENTER, 7178106

What is the Vascular Biogenics website address?

The website address for Vascular Biogenics is www.vblrx.com

Which industry sector does Vascular Biogenics operate in?

Vascular Biogenics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONCBeiGene Ltd	184.14 (731.33%)	28.45k
RAINRain Enhancement Technologies Holdco Inc	5.90 (387.60%)	69.13k
CTCXCarmell Corporation	US$ 0.8965 (221.21%)	222.49M
NITON2OFF Inc	US$ 0.74365 (199.86%)	343.57M
CGBSCrown LNG Holdings Ltd	US$ 0.8401 (109.97%)	239.48M
NMRANeumora Therapeutics Inc	US$ 2.02 (-80.94%)	23.83M
SISIShineco Inc	US$ 2.0701 (-54.30%)	826.02k
HUBCWHub Cyber Security Ltd	US$ 0.02 (-46.74%)	326.5k
BDMDBaird Medical Investment Holdings Ltd	US$ 4.66 (-38.68%)	2.99M
SIDUSidus Space Inc	US$ 3.431 (-29.98%)	7.54M
NITON2OFF Inc	US$ 0.74365 (199.86%)	343.93M
CGBSCrown LNG Holdings Ltd	US$ 0.8401 (109.97%)	240.86M
CTCXCarmell Corporation	US$ 0.8965 (221.21%)	227.6M
XTIAXTI Aerospace Inc	US$ 0.0417 (-3.02%)	137.78M
SVMHSRIVARU Holding Ltd	US$ 0.049 (16.39%)	126.68M